Cargando…
Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission
The long‐term usage of doxorubicin (DOX) is largely limited due to the development of severe cardiomyopathy. Many studies indicate that DOX‐induced cardiac injury is related to reactive oxygen species generation and ultimate activation of apoptosis. The role of novel mitochondrial fission protein 1...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706585/ https://www.ncbi.nlm.nih.gov/pubmed/28643438 http://dx.doi.org/10.1111/jcmm.13250 |
_version_ | 1783282255321366528 |
---|---|
author | Aung, Lynn H. H. Li, Ruibei Prabhakar, Bellur S. Li, Peifeng |
author_facet | Aung, Lynn H. H. Li, Ruibei Prabhakar, Bellur S. Li, Peifeng |
author_sort | Aung, Lynn H. H. |
collection | PubMed |
description | The long‐term usage of doxorubicin (DOX) is largely limited due to the development of severe cardiomyopathy. Many studies indicate that DOX‐induced cardiac injury is related to reactive oxygen species generation and ultimate activation of apoptosis. The role of novel mitochondrial fission protein 1 (Mtfp1) in DOX‐induced cardiotoxicity remains elusive. Here, we report the pro‐mitochondrial fission and pro‐apoptotic roles of Mtfp1 in DOX‐induced cardiotoxicity. DOX up‐regulates the Mtfp1 expression in HL‐1 cardiac myocytes. Knockdown of Mtfp1 prevents cardiac myocyte from undergoing mitochondrial fission, and subsequently reduces the DOX‐induced apoptosis by preventing dynamin 1‐like (Dnm1l) accumulation in mitochondria. In contrast, when Mtfp1 is overexpressed, a suboptimal dose of DOX can induce a significant percentage of cells to undergo mitochondrial fission and apoptosis. These data suggest that knocking down of Mtfp1 can minimize the cardiomyocytes loss in DOX‐induced cardiotoxicity. Thus, the regulation of Mtfp1 expression could be a novel therapeutic approach in chemotherapy‐induced cardiotoxicity. |
format | Online Article Text |
id | pubmed-5706585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57065852017-12-06 Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission Aung, Lynn H. H. Li, Ruibei Prabhakar, Bellur S. Li, Peifeng J Cell Mol Med Original Articles The long‐term usage of doxorubicin (DOX) is largely limited due to the development of severe cardiomyopathy. Many studies indicate that DOX‐induced cardiac injury is related to reactive oxygen species generation and ultimate activation of apoptosis. The role of novel mitochondrial fission protein 1 (Mtfp1) in DOX‐induced cardiotoxicity remains elusive. Here, we report the pro‐mitochondrial fission and pro‐apoptotic roles of Mtfp1 in DOX‐induced cardiotoxicity. DOX up‐regulates the Mtfp1 expression in HL‐1 cardiac myocytes. Knockdown of Mtfp1 prevents cardiac myocyte from undergoing mitochondrial fission, and subsequently reduces the DOX‐induced apoptosis by preventing dynamin 1‐like (Dnm1l) accumulation in mitochondria. In contrast, when Mtfp1 is overexpressed, a suboptimal dose of DOX can induce a significant percentage of cells to undergo mitochondrial fission and apoptosis. These data suggest that knocking down of Mtfp1 can minimize the cardiomyocytes loss in DOX‐induced cardiotoxicity. Thus, the regulation of Mtfp1 expression could be a novel therapeutic approach in chemotherapy‐induced cardiotoxicity. John Wiley and Sons Inc. 2017-06-23 2017-12 /pmc/articles/PMC5706585/ /pubmed/28643438 http://dx.doi.org/10.1111/jcmm.13250 Text en © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Aung, Lynn H. H. Li, Ruibei Prabhakar, Bellur S. Li, Peifeng Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission |
title | Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission |
title_full | Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission |
title_fullStr | Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission |
title_full_unstemmed | Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission |
title_short | Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l‐mediated mitochondrial fission |
title_sort | knockdown of mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting dnm1l‐mediated mitochondrial fission |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706585/ https://www.ncbi.nlm.nih.gov/pubmed/28643438 http://dx.doi.org/10.1111/jcmm.13250 |
work_keys_str_mv | AT aunglynnhh knockdownofmtfp1canminimizedoxorubicincardiotoxicitybyinhibitingdnm1lmediatedmitochondrialfission AT liruibei knockdownofmtfp1canminimizedoxorubicincardiotoxicitybyinhibitingdnm1lmediatedmitochondrialfission AT prabhakarbellurs knockdownofmtfp1canminimizedoxorubicincardiotoxicitybyinhibitingdnm1lmediatedmitochondrialfission AT lipeifeng knockdownofmtfp1canminimizedoxorubicincardiotoxicitybyinhibitingdnm1lmediatedmitochondrialfission |